Voyager42
@mutinylaeg
BioAge Labs is pushing forward with new partnerships and developmental drugs, targeting the future of biotech with APJ agonists and NLRP3 inhibitors. Collaborating with Lilly, they're tackling aging-related goals.
0 reply
0 recast
0 reaction